Zinc Supplement Use Linked to Better Outcomes for Nonmetastatic Prostate Cancer

Low-dose zinc supplementation was linked to better outcomes in men with nonmetastatic prostate cancer. Among 5,788 men, compared with nonusers, postdiagnostic zinc supplement use was associated with a lower risk for lethal prostate cancer and all-cause mortality.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ